PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"35758878","Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk","Moodie Z, Dintwe O, Sawant S, Grove D, Huang Y, Janes H, Heptinstall J, Omar FL, Cohen K, De Rosa SC, Zhang L, Yates NL, Sarzotti-Kelsoe M, Seaton KE, Laher F, Bekker LG, Malahleha M, Innes C, Kassim S, Naicker N, Govender V, Sebe M, Singh N, Kotze P, Lazarus E, Nchabeleng M, Ward AM, Brumskine W, Dubula T, Randhawa AK, Grunenberg N, Hural J, Kee JJ, Benkeser D, Jin Y, Carpp LN, Allen M, D'Souza P, Tartaglia J, DiazGranados CA, Koutsoukos M, Gilbert PB, Kublin JG, Corey L, Andersen-Nissen E, Gray GE, Tomaras GD, McElrath MJ.","J Infect Dis. 2022 Aug 24;226(2):246-257. doi: 10.1093/infdis/jiac260.","Moodie Z","J Infect Dis","2022","2022/06/27","PMC9890908","","10.1093/infdis/jiac260"
"33610126","Immune profiling of Mycobacterium tuberculosis-specific T cells in recent and remote infection","Mpande CAM, Rozot V, Mosito B, Musvosvi M, Dintwe OB, Bilek N, Hatherill M, Scriba TJ, Nemes E; ACS Study Team.","EBioMedicine. 2021 Feb;64:103233. doi: 10.1016/j.ebiom.2021.103233. Epub 2021 Feb 18.","Mpande CAM","EBioMedicine","2021","2021/02/20","PMC7902886","","10.1016/j.ebiom.2021.103233"
"28618268","Antigen Availability Shapes T Cell Differentiation and Function during Tuberculosis","Moguche AO, Musvosvi M, Penn-Nicholson A, Plumlee CR, Mearns H, Geldenhuys H, Smit E, Abrahams D, Rozot V, Dintwe O, Hoff ST, Kromann I, Ruhwald M, Bang P, Larson RP, Shafiani S, Ma S, Sherman DR, Sette A, Lindestam Arlehamn CS, McKinney DM, Maecker H, Hanekom WA, Hatherill M, Andersen P, Scriba TJ, Urdahl KB.","Cell Host Microbe. 2017 Jun 14;21(6):695-706.e5. doi: 10.1016/j.chom.2017.05.012.","Moguche AO","Cell Host Microbe","2017","2017/06/16","PMC5533182","NIHMS881418","10.1016/j.chom.2017.05.012"
"35866359","Achieving intracellular cytokine staining assay concordance on two continents to assess HIV vaccine-induced T-cell responses","Dintwe OB, De Rosa SC, Huang Y, Flach BS, Manso B, Carter D, Omar FL, Schwedhelm KV, Yu C, Lu H, Morris D, Kee JJ, Voillet V, Stirewalt M, Hural J, Moodie Z, Frahm N, Cohen KW, McElrath MJ, Andersen-Nissen E.","J Leukoc Biol. 2022 Nov;112(5):1167-1181. doi: 10.1002/JLB.5MA0522-668R. Epub 2022 Jul 22.","Dintwe OB","J Leukoc Biol","2022","2022/07/22","PMC10229754","NIHMS1894529","10.1002/JLB.5MA0522-668R"
"30830940","A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates","Rodo MJ, Rozot V, Nemes E, Dintwe O, Hatherill M, Little F, Scriba TJ.","PLoS Pathog. 2019 Mar 4;15(3):e1007643. doi: 10.1371/journal.ppat.1007643. eCollection 2019 Mar.","Rodo MJ","PLoS Pathog","2019","2019/03/05","PMC6417742","","10.1371/journal.ppat.1007643"
"31999736","Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans","Zhao LP, Fiore-Gartland A, Carpp LN, Cohen KW, Rouphael N, Fleurs L, Dintwe O, Zhao M, Moodie Z, Fong Y, Garrett N, Huang Y, Innes C, Janes HE, Lazarus E, Michael NL, Nitayaphan S, Pitisuttithum P, Rerks-Ngarm S, Robb ML, De Rosa SC, Corey L, Gray GE, Seaton KE, Yates NL, McElrath MJ, Frahm N, Tomaras GD, Gilbert PB.","PLoS One. 2020 Jan 30;15(1):e0226803. doi: 10.1371/journal.pone.0226803. eCollection 2020.","Zhao LP","PLoS One","2020","2020/01/31","PMC6992005","","10.1371/journal.pone.0226803"
"23737382","Heterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell function","Dintwe OB, Day CL, Smit E, Nemes E, Gray C, Tameris M, McShane H, Mahomed H, Hanekom WA, Scriba TJ.","Eur J Immunol. 2013 Sep;43(9):2409-20. doi: 10.1002/eji.201343454. Epub 2013 Jul 8.","Dintwe OB","Eur J Immunol","2013","2013/06/06","PMC3816254","NIHMS511012","10.1002/eji.201343454"
"29545791","Functional, Antigen-Specific Stem Cell Memory (T(SCM)) CD4(+) T Cells Are Induced by Human Mycobacterium tuberculosis Infection","Mpande CAM, Dintwe OB, Musvosvi M, Mabwe S, Bilek N, Hatherill M, Nemes E, Scriba TJ; SATVI Clinical Immunology Team.","Front Immunol. 2018 Mar 1;9:324. doi: 10.3389/fimmu.2018.00324. eCollection 2018.","Mpande CAM","Front Immunol","2018","2018/03/17","PMC5839236","","10.3389/fimmu.2018.00324"
"23284056","Varicella zoster-specific CD4+Foxp3+ T cells accumulate after cutaneous antigen challenge in humans","Vukmanovic-Stejic M, Sandhu D, Sobande TO, Agius E, Lacy KE, Riddell N, Montez S, Dintwe OB, Scriba TJ, Breuer J, Nikolich-Zugich J, Ogg G, Rustin MH, Akbar AN.","J Immunol. 2013 Feb 1;190(3):977-86. doi: 10.4049/jimmunol.1201331. Epub 2013 Jan 2.","Vukmanovic-Stejic M","J Immunol","2013","2013/01/04","PMC3552094","NIHMS423698","10.4049/jimmunol.1201331"
"30919583","OMIP-056: Evaluation of Human Conventional T Cells, Donor-Unrestricted T Cells, and NK Cells Including Memory Phenotype by Intracellular Cytokine Staining","Dintwe O, Rohith S, Schwedhelm KV, McElrath MJ, Andersen-Nissen E, De Rosa SC.","Cytometry A. 2019 Jul;95(7):722-725. doi: 10.1002/cyto.a.23753. Epub 2019 Mar 28.","Dintwe O","Cytometry A","2019","2019/03/29","PMC6663658","NIHMS1018447","10.1002/cyto.a.23753"
"31989802","Corrigendum: OMIP-056: Evaluation of Human Conventional T Cells, Donor-Unrestricted T Cells, and NK Cells Including Memory Phenotype by Intracellular Cytokine Staining","Dintwe O, Rohith S, Schwedhelm KV, McElrath MJ, Andersen-Nissen E, De Rosa SC.","Cytometry A. 2020 Feb;97(2):199-201. doi: 10.1002/cyto.a.23962. Epub 2020 Jan 6.","Dintwe O","Cytometry A","2020","2020/01/29","PMC8094202","","10.1002/cyto.a.23962"
"31900486","Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein","Hosseinipour MC, Innes C, Naidoo S, Mann P, Hutter J, Ramjee G, Sebe M, Maganga L, Herce ME, deCamp AC, Marshall K, Dintwe O, Andersen-Nissen E, Tomaras GD, Mkhize N, Morris L, Jensen R, Miner MD, Pantaleo G, Ding S, Van Der Meeren O, Barnett SW, McElrath MJ, Corey L, Kublin JG; HVTN 111 Protocol Team.","Clin Infect Dis. 2021 Jan 23;72(1):50-60. doi: 10.1093/cid/ciz1239.","Hosseinipour MC","Clin Infect Dis","2021","2020/01/05","PMC7823071","","10.1093/cid/ciz1239"
"32382714","A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa","Bekker LG, Dintwe O, Fiore-Gartland A, Middelkoop K, Hutter J, Williams A, Randhawa AK, Ruhwald M, Kromann I, Andersen PL, DiazGranados CA, Rutkowski KT, Tait D, Miner MD, Andersen-Nissen E, De Rosa SC, Seaton KE, Tomaras GD, McElrath MJ, Ginsberg A, Kublin JG; HVTN 602/Aeras A-042 Protocol Team.","EClinicalMedicine. 2020 Mar 18;21:100313. doi: 10.1016/j.eclinm.2020.100313. eCollection 2020 Apr.","Bekker LG","EClinicalMedicine","2020","2020/05/09","PMC7201034","","10.1016/j.eclinm.2020.100313"
"25862299","A randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Guérin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syringe","Geldenhuys HD, Mearns H, Foster J, Saxon E, Kagina B, Saganic L, Jarrahian C, Tameris MD, Dintwe OB, Van Rooyen M, Luabeya KK, Hussey G, Scriba TJ, Hatherill M, Zehrung D.","Vaccine. 2015 Sep 8;33(37):4719-26. doi: 10.1016/j.vaccine.2015.03.074. Epub 2015 Apr 7.","Geldenhuys HD","Vaccine","2015","2015/04/12","PMC4564069","","10.1016/j.vaccine.2015.03.074"
"32442195","Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials","Moodie Z, Walsh SR, Laher F, Maganga L, Herce ME, Naidoo S, Hosseinipour MC, Innes C, Bekker LG, Grunenberg N, Mann P, Yu C, deCamp AC, Miner MD, Yates NL, Heptinstall J, Mkhize NN, Dintwe O, Frahm N, Cohen KW, Allen M, Hutter J, Wagner R, Pantaleo G, McElrath MJ, Tomaras GD, Morris L, Montefiori DC, Andersen-Nissen E, Gray GE, Gilbert PB, Kublin JG; NIAID HVTN 100 and HVTN 111 trial teams.","PLoS Med. 2020 May 22;17(5):e1003117. doi: 10.1371/journal.pmed.1003117. eCollection 2020 May.","Moodie Z","PLoS Med","2020","2020/05/23","PMC7244095","","10.1371/journal.pmed.1003117"
